Concepedia

Tumor-associated inflammation as a potential prognostic tool in BRCA1/2-associated breast cancer

Victorien M.T. van Verschuer, Maartje J. Hooning, Radka D. van Baare-Georgieva, Antoinette Hollestelle, Anne Timmermans, Linetta B. Koppert, Leon C. Verhoog, John W.M. Martens, Caroline Seynaeve, Carolien H. M. van Deurzen

Human Pathology · 2014 · 30 citations · 26 references

DOI

Concepts

References

26

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

C.W. Elston, Ian O. Ellis · Histopathology · 1991 · 6.1K citations

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations

The Risk of Cancer Associated with Specific Mutations of<i>BRCA1</i>and<i>BRCA2</i>among Ashkenazi Jews

Jeffery P. Struewing, Patricia Hartge, Sholom Wacholder et al. · New England Journal of Medicine · 1997 · 2.3K citations · Full text

Breast and Ovarian Cancer Risks Due to Inherited Mutations in <i>BRCA1</i> and <i>BRCA2</i>

Mary‐Claire King, Joan H. Marks, Jessica B. Mandell · Science · 2003 · 2.2K citations

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

Carsten Denkert, Sibylle Loibl, Aurelia Noske et al. · Journal of Clinical Oncology · 2009 · 1.8K citations

, , +17